Escherichia coli EF-16
Ancestors
Derived strains
Genotype with respect to parental
ilvG::Ptac-yigB
Genotype with respect to wild type
F+ (λ) | λ- | F- λ- ilvG- rfb-50 rph-1 | △lacI | Plasmid pduet-rib added | △pfkA | △edd△eda | △ribB-FMN riboswitch | ribF::PJ23111-ribCG199D | △purR | ybeM::Ptac-prs-purF | yncI::Ptac-gmk-ndk | ycgH::Ptac-rpiA-rpiB | yghX::Ptac-pgl | ylbE:Ptac-gnd | ilvG::Ptac-yigBBars (|) indicate differences between strains.
Plasmids
-
pduet-rib (Ptac-ribEDAH)
Modifications
| Origin | Gene | Organism | Modification |
|---|---|---|---|
|
Silencing
|
|||
|
Silencing
|
|||
|
Silencing
|
|||
|
Silencing
|
|||
|
Feedback insensitive
|
|||
|
Silencing
|
|||
|
Attenuation
|
|||
|
Silencing
|
|||
|
Silencing
|
|||
|
Overexpression
|
|||
|
Overexpression
|
|||
|
Silencing
|
|||
|
Overexpression
|
|||
|
Overexpression
|
|||
|
Silencing
|
|||
|
Overexpression
|
|||
|
Overexpression
|
|||
|
Silencing
|
|||
|
Overexpression
|
|||
|
Silencing
|
|||
|
Overexpression
|
|||
|
Silencing
|
|||
|
Overexpression
|
|||
|
Overexpression
|
|||
|
Overexpression
|
|||
|
Overexpression
|
|||
|
Overexpression
|
Production
| Metabolites | Production type | Production | Biomass | Carbon source | Time | Scale | Ref. |
|---|---|---|---|---|---|---|---|
| riboflavin | Titer | 1378.2 mg/L | Flask | [324] | |||
| riboflavin | Titer | 2205.5 mg/L | Flask | [324] | |||
| riboflavin | Substrate yield | 110.2 mg/g of sustrate | Flask | [324] | |||
| riboflavin | Titer | 11.6 g/L | 48 h | Fed-Batch | [324] | ||
| riboflavin | Substrate yield | 80.3 mg/g of sustrate | 48 h | Fed-Batch | [324] |
* Inferred from plots using RetroPlot.
Heterologous.
Target metabolites are shown in bold, while non-bold metabolites represent intermediates or potential byproducts.
References
- Zhang, Xiaoling; Li, Yanan; Wang, Kang; Yin, Jilong; Du, Yuxuan; Yang, Zhen; Pan, Xuewei; You, Jiajia & Rao, Zhiming. Construction of antibiotic-free riboflavin producer in Escherichia coli by metabolic engineering strategies with a plasmid stabilization system. Synthetic and Systems Biotechnology. 2025, 10(2), 346-355.